logo-loader
viewIntegumen

Integumen and Modern Water begin production of monitoring bacteria reagent ahead of schedule

The AIM-listed firm said the reagent will be used to identify contamination in wastewater from residential, hospital and municipal sewage treatment outflows

Integumen - Integumen and Modern Water begin production of monitoring bacteria reagent ahead of schedule

Integumen PLC (LON:SKIN) and its partner Modern Water Plc (LON:MWG) have begun production of the latter’s monitoring bacteria reagent six weeks ahead of schedule due to the coronavirus pandemic.

The two companies announced a three-year deal on March 18 for Integumen to manufacture and provide logistical support for Modern Water’s monitoring reagent consumables, which is expected to be worth a headline £3.12mln.

WATCH: Integumen begins immediate production of Modern Water's monitoring bacteria reagent

Integumen said the enlargement of its laboratories has begun with the ordering of new equipment, while the bacteria manufactured by Modern Water will be used to identify contamination in wastewater outlets from residential, hospital and municipal sewage treatment outflows that may contribute to the current public health crisis.

As previously announced, Integumen said that it will be investing £250,000 to rapidly expand its laboratories in York to 6,000 square feet to accelerate production of the bacteria reagent and maintain growth of its own Labskin product.

“We are now able to bring water contamination detection bacteria faster to the frontline environmental inspection teams, in crisis countries, where there is currently insufficient supply”, Integumen chief executive Gerard Brandon said in a statement.

"Integumen is in a strong position to provide the support for Modern Water and all their customers across the world through delivery of integrated engineering, scientific and real-time data analytical solutions in order to address this major societal and global problem in healthcare and the environment", he added.

Shares in Integumen jumped 7.6% to 1.1p in early deals on Monday.

Quick facts: Integumen

Price: 1.65 GBX

AIM:SKIN
Market: AIM
Market Cap: £17.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 rises despite worst ever UK construction numbers

Headlines from the Proactive UK newsroom. The FTSE 100 rose 23 to 5,782 in spite of the worst UK construction numbers ever recorded. April’s PMI number tumbled to 8.2 from 39.3 in March as the coronavirus impact bit hard. Ocado’s revenue surged by 40% in its latest quarter though it says...

3 weeks, 4 days ago

2 min read